$800 Million Baby !!!

The Trolly Troll is back
Hate and more hate
How SAD

Despite your malevolous wishes
Acorda will triumph

Go back under that rock where you reside
Be quiet, observe and learn on how to succeed against adversity

Acorda will show you how

 

So easy to hear the negative nancies whining and crying about how the world will end because the sky is falling. Come on people, rally cap time. You know we are poised on the edge of the greatest new product launch that will revive the top line, drive the bottom line and have investors swoon with happy smiles on their faces. I just reviewed my targets for the upcoming week, where can we drive volume, where can I open a closed door, what can make my whales continue to grow. Ya Baby that's what it's all about. Bonus work for Bonus Pay. We got this.

 

Have fun out there tomorrow trying to sell a product that won’t be approved until October in offices that are closed. The only thing you are capable of driving is your boyfriend crazy.

$325

 

early bird gets the worm. Yes $325 a share next year. Why do you think it’s called a seeding study ?

 

Thanks for the hot tip MR. Buffett!

You will be lucky to see $55 on a sale.

I’ll look forward to the results of your marketing trial. I’m sure the payments to key docs won’t have any influence on the price you have to charge to cover it. Should make for some interesting tweeting from the chief SJW

 

"Seeding study"

What is this about?

 

Look you moron, ACOR is set to make a major upward move. BTW I have graduate degrees in business economics and as part of my MBA have performed case studies on hedge funds which made many millions on plays in pharma like ACOR. I fully expect a price runup by the funds as they see the potential in Inbrija. They also know Leadership has superior capabilities to pull this off. Citing Bershire Hathaway actually supports this argument as they are big time fans.

So before you make a total fool of yourself predicting a mere $55 share price go back to school and work on a business or economics degree. I suspect you are a ham and egg armchair 'expert'.

 

Your numerous “case studies” aside, you have yet to provide one bit of information to substantiate any of your “feelings” on the upside you are projecting. Analogues don’t support it, your stock price and two year trend don’t support it, past decision making and performance don’t support it, the payer environment doesn’t support it, but we will go ahead with your vast experience from hedge fund summer camp.

 

Our Leadership is optimistic that these numbers will be reached. We must show our support to our CEO and his inner circle. Fortunately 94% of our team sees it that way based on latest Glassdoor survey. That you chose to ignore relevant case studies shows you lack a strong analytical background. We will meet $800!!! Past miscues by intern employees aside our team projects timnely approval and.a stable. price point w/o ffurther deterioration based on a fairly inelastic supply demand environment. Trust us. We work long hours to make success a reality.

 

Junior, you crack me up. Your mama gene that team isn’t optimistic, they are desperate for someone to buy this BS you are selling.

Here’s an idea for you given your superior analytical and economics acumen. Tell the FDA you have an excellent Glassdoor rating and you would like expedited approval and labeling that shows superiority to other LD products. I’m sure they will bow to your superior intellect after you show them how to do statistical analysis based on your impressive class project (case study) background.

Now STFU and go make coffee like they are paying you for!

 

You are obviously ignorant of the power of the scientific method and statistical analysis (BTW FDA understands this). The well-known Central Limit Theorem is applied to expedite the approval data and therefore our timeline compliance..

Recommend you do some scientific brushing up before denigrating it. You appear to be a victim of Groupthink (ref. "Victims of Groupthink" by Irving Janis in your free time).

 

Irving Janis, no

Janis Joplin, absolutely YES

Let's rock Acorda with some good music while the shares go up up and away !!!

 

LMAO. You are such an idiot

 

$325M

 

Revisiting some of Habib's past prognostications.

Hopefully you got a new financial advisor!

 

Those numbers were maybe slightly optomistic but Inbrija will shake the world !!!!!!!!

 

you better hurry up before the patent expires, you have been on the market 2 years with low low low sales, and more excuses than a prostitute going to jail.

 

Habib,

The only thing MeTooDopa will be remembered for is being an unnecessary reformulation that never took off.

It will be used as an analogue by consultants when guiding other companies on what to develop or not develop.

 

The Covid delayed the role out of Inbija !!! So now that it is going great the REBOUND is underway/ Look for major jack in share price as Inbrija goes WORLD WIDE. Investers must have patents !!!

 

❌Multiple sources have determined that the delay in MeTooDopa was due to a poor NDA filing, followed by poor market preparation and lackluster performance for a year pre Covid. The continued decline of value leading to imminent bankruptcy flies in the face of any “rebound”❌